Finance Home - My Yahoo - Yahoo! - Help

Friday, January 8, 2010, 4:00PM ET - U.S. Markets Closed. Dow  0.10% Nasdaq  0.74%

GlaxoSmithKline plc (GSK)

At 3:45PM ET: 41.10   0.38 (0.92%)

MORE ON GSK

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Nov 3, 2009 • Are Swine Flu Fears Overblown? at BusinessWeek (Tue, Nov 3) • 10 Stocks Shaking the Market at Motley Fool (Tue, Nov 3) • GSK, Pfizer launch HIV company at bizjournals.com (Tue, Nov 3) • 5-Star Stocks Worth a Look at Motley Fool (Tue, Nov 3) • This Just In: Upgrades and Downgrades at Motley Fool (Tue, Nov 3) • Stock Picks: Nordstrom, Airgas at BusinessWeek (Tue, Nov 3) • Healthcare Reform Bill Net Neutral To Positive For Pharmaceutical Industry According To Analysis By Morningstar Expert Wall Street Transcript (Tue, Nov 3) • Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com GlobeNewswire (Tue, Nov 3) • GlaxoSmithKline Launches Specialist HIV Company at SmartMoney.com (Tue, Nov 3) Mon, Nov 2, 2009 • IBD's Top 10 - Monday Investor's Business Daily (Mon, Nov 2) • FDA Official Urges Caution on New H1N1 Drug at CNBC (Mon, Nov 2) • [$$] Stocks in the Spotlight Monday at Barrons.com (Mon, Nov 2) • Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase Wall Street Transcript (Mon, Nov 2) • Stocks End Volatile Day With Uneven Gains at SmartMoney.com (Mon, Nov 2) • CEO Interview: Aeolus Pharmaceuticals, Inc. - John L. McManus Wall Street Transcript (Mon, Nov 2) • Finally Convinced? Benlysta Works! at Motley Fool (Mon, Nov 2) • Biotech Stocks: Human Genome rallies, GTX craters at MarketWatch (Mon, Nov 2) • [video] Human Genome, Glaxo Lupus Drug Moves Forward at CNBC (Mon, Nov 2) • Genomics: No Longer A Failure at Forbes.com (Mon, Nov 2) • Biotech Stocks: Human Genome, Vertex, Amylin in play at MarketWatch (Mon, Nov 2) • Swine Flu Stock Picking Rewards Winners Handsomely Indie Research (Mon, Nov 2) • Indications: U.S. stock futures climb ahead of ISM report at MarketWatch (Mon, Nov 2) • Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Systemic Lupus Erythematosus Business Wire (Mon, Nov 2) • Human Genome Calls Second Lupus Drug Study a Success at TheStreet.com (Mon, Nov 2) • Human Genome, GSK see progress with lupus drug at MarketWatch (Mon, Nov 2) Older Headlines - Most Recent Headlines View headlines from: Mon, Nov 2, 2009Mon, Oct 26, 2009Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009Mon, Sep 7, 2009Mon, Aug 31, 2009 Add GSK News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage